Clinical Trials Logo

Filter by:
NCT ID: NCT00325208 Recruiting - Healthy Infants Clinical Trials

Feeding Bottle Design, Milk Intake and Infant Growth

Start date: n/a
Phase: N/A
Study type: Interventional

It is increasingly recognised that rapid growth in infancy may be associated with a greater risk of cardiovascular disease later in life. This trial will investigate whether the use of infant feeding bottles with different designs influences the milk intake and growth of infants. We will compare the growth of bottle-fed infants with that of a breast-fed reference group.

NCT ID: NCT00308321 Recruiting - Nephrotic Syndrome Clinical Trials

Long Term Tapering or Standard Steroids for Nephrotic Syndrome

Start date: September 2003
Phase: Phase 4
Study type: Interventional

Parallel group double blind randomised in patients with first episode corticosteroid sensitive nephrotic syndrome comparing time to relapse and adverse effects associated with a longer tapering steroid regimen with standard regime

NCT ID: NCT00305838 Recruiting - Ovarian Cancer Clinical Trials

CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

Start date: March 2004
Phase: Phase 2
Study type: Interventional

RATIONALE: Estrogen may cause the growth of ovarian cancer cells. Hormone therapy using tamoxifen may fight ovarian cancer by blocking the use of estrogen by the tumor cells. Measuring CA 125 levels may help doctors predict a patient's response to tamoxifen and help plan the best treatment. PURPOSE: This phase II trial is studying CA 125 levels in treating patients with relapsed advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who are receiving tamoxifen.

NCT ID: NCT00303784 Recruiting - Prostate Cancer Clinical Trials

Prostate Adenocarcinoma TransCutaneous Hormones

PATCH
Start date: March 2006
Phase: Phase 3
Study type: Interventional

RATIONALE: The increasingly prolonged and extended use of androgen deprivation therapy (ADT) in the treatment of prostate cancer, usually achieved through the administration of LHRH agonists, has raised concerns about long-term toxicities, in particular osteoporosis and adverse metabolic changes which may be associated with type II diabetes and increased cardiovascular risk. An alternative approach is to investigate other methods of ADT. Oral oestrogen has been shown to be as effective as LHRH and surgical orchidectomy in achieving castrate levels of testosterone and has equivalent or improved prostate cancer outcomes but is not used routinely as first-line therapy because of the risk of cardiovascular system (CVS) complications. The CVS complications have been attributed to first-pass hepatic metabolism. Administering oestrogen parenterally avoids the entero-hepatic circulation and so is expected to mitigate the risk of CVS toxicity whilst still effectively suppressing testosterone to castrate levels. This hypothesis has been supported by results from the early stages of this trial which have provided sufficient indication of the safety and efficacy of the patches to warrant further investigation of the treatment in this setting, as recommended by the IDMC.. PURPOSE: This randomized phase III trial is studying how well the estrogen skin patch works compared with luteinizing hormone-releasing hormone agonist injections in treating patients with locally advanced or metastatic prostate cancer.

NCT ID: NCT00301535 Recruiting - Clinical trials for Coronary Artery Disease

A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery

Start date: February 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if Hemopure® will enhance tissue preservation during Cardiopulmonary Bypass surgery.

NCT ID: NCT00300352 Recruiting - Clinical trials for Coronary Artery Disease

Effect of Folic Acid Treatment in Coronary Artery Disease

Start date: May 2004
Phase: Phase 2
Study type: Interventional

We seek to examine the effects of folic acid treatment on vascular function in patients with coronary artery disease. Our hypothesis is that folic acid treatment will improve vascular function

NCT ID: NCT00299442 Recruiting - Behavioral Symptoms Clinical Trials

Self-Help Parent Training for Conduct Problems in Children

Start date: July 2007
Phase: Phase 3
Study type: Interventional

This project will introduce a self-help parent training programme for families on National Health Service (NHS) waiting lists for child mental health services. It will examine whether access to treatment can be increased by providing an intervention that requires fewer resources and by releasing clinician time for more serious cases. This intervention will be tested in a randomised, controlled trial in which 35 subjects will receive treatment immediately and 35 will receive treatment after waiting for 10 weeks. All families will also complete questionnaires before and after the 10 week study period in order to measure changes in child behaviour, parenting, and parental mental health. Cost-effectiveness of this programme will also be analysed. Intention-to-treat analyses will be conducted.

NCT ID: NCT00299299 Recruiting - Clinical trials for Patients With Liver Metastases From Colorectal Cancer

Modelling Internal Hepatic Movement With an External Abdominal Marker

Start date: June 2006
Phase: N/A
Study type: Observational

This study tests the feasibility and reproducibility of patient-specific motion models. These will be used for quantification of safe margin reduction. Patient-specific motion models will be built by post-processing 4D MRI data with non-rigid registration. By comparing these models between visits, model reproducibility will be assessed, and the methodology refined.

NCT ID: NCT00292175 Recruiting - Ulcerative Colitis Clinical Trials

NBI With Magnification for Dysplasia Detection in Ulcerative Colitis

Start date: February 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether a new colonoscopic viewing technique called narrow band imaging (NBI) helps doctors detect more patients with at leat one pre-cancerous area (dysplasia associated lession or mass, MALMs) than conventional colonoscopy using white light alone.

NCT ID: NCT00279357 Recruiting - Adenomas Clinical Trials

Randomised Trial of NBI for Adenoma Detection

Start date: January 2006
Phase: N/A
Study type: Interventional

Does a new colonoscopic viewing technique called narrow band imaging (NBI) help doctors detect more patients with at least one pre-cancerous polyp (adenoma) than conventional colonoscopy using white light alone? May 2007 protocol minor amendment: additional viewing by endoscopists outside St Mark's ro allow assessment of inter- and intra-observer variability.